Who owns Beam Therapeutics Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of BEAM from SEC Form 13F filings across 277 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 277 institutions disclosed 109.4M shares of Beam Therapeutics Inc. worth $4.10B — about 104.9% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
277
13F holders
$4.10B
value, 2026 filers
104.9%
of shares outstanding (109.4M sh)
63
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of BEAM's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 12.6M | $432.7M | 0.0% | 12.1% | +1.3% |
| 2 | FARALLON CAPITAL MANAGEMENT, L.L.C. | 10.2M | $351.3M | 1.6% | 9.8% | +1.0% |
| 3 | ARK Investment Management LLC | 10.2M | $351.3M | 2.3% | 9.8% | -15.6% |
| 4 | BlackRock, Inc. | 9.0M | $308.8M | 0.0% | 8.6% | +6.0% |
| 5 | STATE STREET CORP | 5.8M | $200.0M | 0.0% | 5.6% | +2.2% |
| 6 | VANGUARD PORTFOLIO MANAGEMENT LLC | 4.9M | $168.9M | 0.0% | 4.7% | +7.7% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 4.6M | $157.9M | 0.0% | 4.4% | +5.1% |
| 8 | ARCH Venture Management, LLC | 4.5M | $155.8M | 14.2% | 4.4% | 0.0% |
| 9 | Sumitomo Mitsui Trust Group, Inc. | 3.5M | $118.6M | 0.1% | 3.3% | -9.7% |
| 10 | Amova Asset Management Americas, Inc. | 3.5M | $118.5M | 1.5% | 3.3% | -9.7% |
| 11 | PRICE T ROWE ASSOCIATES INC /MD/ | 3.4M | $117.2M | 0.0% | 3.3% | +25.9% |
| 12 | Kynam Capital Management, LP | 2.8M | $97.5M | 5.4% | 2.7% | -22.9% |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | 2.6M | $89.1M | 0.0% | 2.5% | +7.4% |
| 14 | DIMENSIONAL FUND ADVISORS LP | 2.2M | $76.4M | 0.0% | 2.1% | +3.3% |
| 15 | MORGAN STANLEY | 2.0M | $67.0M | 0.0% | 1.9% | +201.0% |
| 16 | Contrarius Group Holdings Ltd | 1.6M | $55.4M | 2.6% | 1.5% | +202.7% |
| 17 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1.6M | $53.3M | 0.0% | 1.5% | -6.2% |
| 18 | TWO SIGMA INVESTMENTS, LP | 1.4M | $47.6M | 0.0% | 1.3% | +14.6% |
| 19 | Casdin Capital, LLC | 1.4M | $46.3M | 2.3% | 1.3% | 0.0% |
| 20 | GOLDMAN SACHS GROUP INC | 1.3M | $45.0M | 0.0% | 1.3% | +30.3% |
| 21 | Redmile Group, LLC | 1.2M | $40.0M | 2.7% | 1.1% | -5.9% |
| 22 | BNP PARIBAS FINANCIAL MARKETS | 1.1M | $36.6M | 0.0% | 1% | +52.4% |
| 23 | Deep Track Capital, LP | 1.0M | $34.3M | 0.5% | 1% | +21.8% |
| 24 | NORTHERN TRUST CORP | 933,481 | $32.0M | 0.0% | 0.9% | +13.1% |
| 25 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 885,902 | $30.4M | 0.0% | 0.8% | +9.6% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.